Solveig Blomvik

Chief Executive Officer, Vanturi ApS

Borgervænget 131 active role

Solveig Blomvik holds 1 active role in Danish companies registered in CVR, including Chief Executive Officer at Vanturi ApS since 2026. Solveig Blomvik is registered as legal owner of Vanturi ApS (33.33–49.99% share band). 2 earlier roles have ended, the most recent in 2018.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2026 – now
Chief Executive Officer, Vanturi ApS
2017 – 2018
Board of Directors, PharmaLex Denmark A/S
2016 – 2018
Management, Pharmalex Nordic ApS

Personal details

Address

Borgervænget 13

Companies & roles

Active roles

1 positions

Company	Role	Period	Ownership	Status
Vanturi ApS CVR 37549304	ManagementChief Executive Officer	Since 2026	33.33–49.99%	Active

Historical roles

2 positions

Company	Role	Period	Ownership	Status
Pharmalex Nordic ApS CVR 37541540	ManagementManagement	2016 – 2018	—	Active
PharmaLex Denmark A/S CVR 18652439	BoardBoard of Directors	2017 – 2018	—	Active

Network

Company network

Active roles

Solveig Blomvik

Vanturi ApS

Chief Executive Officer

Past companies

Pharmalex Nordic ApS PharmaLex Denmark A/S

Co-directors & shared companies

Person	Role	Shared companies	Profile
SL Steen Lindequist	Legal Owner	1company	View profile

Is this you? About the data on this page

This profile is compiled automatically from CVR / Virk, the official business register in Denmark. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.